G

GeneBioTech Co Ltd
KOSDAQ:086060

Watchlist Manager
GeneBioTech Co Ltd
KOSDAQ:086060
Watchlist
Price: 4 055 KRW -0.61% Market Closed
Market Cap: 34.9B KRW

Wall Street
Price Targets

Price Targets Summary
GeneBioTech Co Ltd

There are no price targets for GeneBioTech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GeneBioTech Co Ltd Competitors:
Price Targets
RARE
Ultragenyx Pharmaceutical Inc
145% Upside
PHARM
Pharming Group NV
45% Upside
PHIL
Philogen SpA
13% Upside
COV
Covalon Technologies Ltd
71% Upside
QTTB
Homology Medicines Inc
261% Upside
206650
EuBiologics Co Ltd
68% Upside
2256
Abbisko Cayman Ltd
79% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
90% Upside

Revenue
Forecast

Revenue Estimate
GeneBioTech Co Ltd

For the last 13 years the compound annual growth rate for GeneBioTech Co Ltd's revenue is 8%. The projected CAGR for the next 13 years is -11%.

8%
Past Growth
-11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
GeneBioTech Co Ltd

Operating Income forecast
is not available for
GeneBioTech Co Ltd

Net Income
Forecast

Net Income Estimate
GeneBioTech Co Ltd

For the last 13 years the compound annual growth rate for GeneBioTech Co Ltd's net income is 14%. The projected CAGR for the next 13 years is -3%.

14%
Past Growth
-3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GeneBioTech Co Ltd's stock price target?
Not Available

GeneBioTech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is GeneBioTech Co Ltd's Revenue forecast?
Projected CAGR
-11%

For the last 13 years the compound annual growth rate for GeneBioTech Co Ltd's revenue is 8%. The projected CAGR for the next 13 years is -11%.

What is GeneBioTech Co Ltd's Net Income forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for GeneBioTech Co Ltd's net income is 14%. The projected CAGR for the next 13 years is -3%.

Back to Top